Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine

Hum Vaccin Immunother. 2014;10(5):1181-6. doi: 10.4161/hv.28332. Epub 2014 Mar 10.

Abstract

The relationship between obesity and vaccine efficacy is a serious issue. Previous studies have shown that vaccine efficacy is lower in the obese than in the non-obese. Here, we examined the influence of obesity on the efficacy of influenza vaccination using high fat diet (HFD) and regular fat diet (RFD) mice that were immunized with 2 types of influenza virus vaccines-cell culture-based vaccines and egg-based vaccines. HFD mice showed lower levels of neutralizing antibody titers as compared with RFD mice. Moreover, HFD mice showed high levels of MCP-1 in serum and adipocytes, and low level of influenza virus-specific effector memory CD8(+) T cells. After challenge with influenza virus, the lungs of HFD mice showed more severe inflammatory responses as compared with the lungs of RFD mice, even after vaccination. Taken together, our data suggested that the inflammatory condition in obesity may contribute to the suppressed efficacy of influenza vaccination.

Keywords: high fat diet; inflammation; influenza virus; obesity; vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes / immunology
  • Chemokine CCL2 / blood
  • Diet, High-Fat / adverse effects
  • Inflammation / blood
  • Inflammation / etiology
  • Inflammation / immunology
  • Influenza Vaccines / administration & dosage*
  • Influenza Vaccines / therapeutic use
  • Lung / drug effects
  • Lung / immunology
  • Lung / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Obesity / blood
  • Obesity / complications*
  • Obesity / immunology*
  • Treatment Outcome

Substances

  • Ccl2 protein, mouse
  • Chemokine CCL2
  • Influenza Vaccines